Elevation of CRABP-I in the cerebrospinal fluid of patients with moyamoya disease
Elevation of CRABP-I in the cerebrospinal fluid of patients with moyamoya disease
复制标题
DOI:
10.1161/01.str.0000100159.43123.d7
复制
发表时间:
2003-12-01
期刊:
影响因子:
8.3
通讯作者:
Wang, KC
中科院分区:
文献类型:
--
作者:
Kim, SK;Yoo, JI;Wang, KC
Background and Purpose - The etiology of moyamoya disease ( MMD) remains obscure. This study was undertaken to identify specific proteins associated with the pathogenesis of MMD.Methods - We studied cerebrospinal fluid ( CSF) from 20 patients with angiographically confirmed MMD ( 4 boys and 16 girls; age range, 3 to 13 years; mean, 7.5 years) and 4 control patients with cerebral palsy who underwent selective dorsal rhizotomy ( 2 boys and 2 girls; age range, 5 to 10 years; mean, 7.3 years). CSF proteins were analyzed by 2- dimensional polyacrylamide gel electrophoresis, and protein identification was performed by matrix- assisted laser desorption/ ionization time- of- flight mass spectrometry. The presence of specific CSF protein in patients with MMD was confirmed by Western blotting. In addition, cerebral CSF was also tested in 7 patients who had other brain diseases but no MMD ( 2 boys and 5 girls; age range, 1 to 12 years; mean, 6.9 years).Results - We identified 1 polypeptide spot ( M-r of 13 to 15 kDa and isoelectric point of 5 to 5.5) that was differentially expressed in the CSF samples of MMD patients ( mean optical density intensity, 0.36 +/- 0.24; range, 0.05 to 0.92) and control spinal CSF samples ( mean, 0.03 +/- 0.04; range, 0 to 0.08; P = 0.002). This polypeptide was identified as cellular retinoic acid - binding protein ( CRABP)- I. High levels of expression of CRABP- I in the CSF from 17 MMD children were confirmed by Western blotting.Conclusions - The analysis of the CSF of MMD patients reveals high CRABP- I expression. The present study suggests that the elevation of CRABP- I in CSF may be a candidate for pathogenesis of MMD.